InvestorsHub Logo
Followers 2
Posts 113
Boards Moderated 0
Alias Born 10/05/2018

Re: elkonig post# 22991

Friday, 01/25/2019 1:34:53 PM

Friday, January 25, 2019 1:34:53 PM

Post# of 32923
NCM Biotech may or may not lay out a revenue stream during their call next week

They mentioned in the PR an update on their gummies/mints/etc as well

Without a revenue stream, it is clear why they have been diluting

They have alot to turn around, starting with the CE, but it is all very doable, and in the near term

Just need hard figures on their business plan for 2019:

1. How many/Who are interested in their extraction patent?
a. How much do they make per month for franchise revenue per agreement?
2. How far along are they on Medical CBD research/trials using their extraction process for COPD/Asthma/etc.? And how do they plan on revenue from the research? Any new medical patents?
a. How do they plan on raising funds for further research/trials without diluting?
3. What CBD water/tea/etc do they plan on releasing under their own brand? Or are they just planning on extracting for other companies? (PURA, GNBT, etc.)
4. What marketing do they have in place for future hemp farmers finding them and using their extraction process?